GenSight Biologics S.A.: GenSight Biologics Provides Update on LUMEVOQ Manufacturing and Commercialization Timelines
PPQ campaign to start early May 2023 (previously end of March) with results expected in Q3 2023 EMA CHMP opinion now expected in Q1 2024 (previously September 2023) Regulatory News: GenSight